Last reviewed · How we verify
Sampling bone tissue
Bone tissue sampling is a diagnostic procedure that obtains bone tissue specimens for histological, biochemical, or molecular analysis.
Bone tissue sampling is a diagnostic procedure that obtains bone tissue specimens for histological, biochemical, or molecular analysis. Used for Diagnostic evaluation of metabolic bone disease, Assessment of bone quality and mineralization, Investigation of unexplained bone pathology.
At a glance
| Generic name | Sampling bone tissue |
|---|---|
| Sponsor | Radboud University Medical Center |
| Modality | Small molecule |
| Therapeutic area | Diagnostics |
| Phase | FDA-approved |
Mechanism of action
This is a clinical diagnostic technique rather than a pharmaceutical drug. It involves percutaneous or surgical collection of bone tissue to evaluate bone quality, mineralization, turnover, pathology, or disease state. The samples are analyzed through microscopy, immunohistochemistry, or other laboratory methods to diagnose metabolic bone diseases, infections, malignancies, or other bone disorders.
Approved indications
- Diagnostic evaluation of metabolic bone disease
- Assessment of bone quality and mineralization
- Investigation of unexplained bone pathology
- Evaluation of bone infection or malignancy
Common side effects
- Local pain at biopsy site
- Bleeding or hematoma
- Infection
Key clinical trials
- Project: Every Child for Younger Patients With Cancer
- MICRO-SURG: Subgingival Microbiome in Peri-Implantitis, Regenerative, and Resective Periodontal Surgery (NA)
- Use of Acupressure, Aromatherapy, and Virtual Reality for Children in During Blood Collection Procedures (NA)
- A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours (NA)
- Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse (NA)
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
- Assessing Durable Antibody Response to HPV Vaccination (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sampling bone tissue CI brief — competitive landscape report
- Sampling bone tissue updates RSS · CI watch RSS
- Radboud University Medical Center portfolio CI